Literature DB >> 10741725

Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.

S Y Rha1, E Izbicka, R Lawrence, K Davidson, D Sun, M P Moyer, G D Roodman, L Hurley, D Von Hoff.   

Abstract

Shortening of telomeres along with an up-regulation of telomerase is implicated in the immortality of tumor cells. Targeting either telomeres or telomerase with specific compounds has been proposed as an anticancer strategy. Because telomerase activity and telomeres are found in normal cells, telomere or telomerase targeting agents could induce side effects in normal tissues. We evaluated the effects of telomere and telomerase interactive agents in human tumor and normal cell lines to try to determine the potential side effects those agents might induce in patients. Toxicity of the G-quadruplex interactive porphyrins (TMPyP4, TMPyP2) and azidothymidine (AZT) were tested using a cell-counting technique against normal human cell lines (CRL-2115 and CRL-2120, fibroblasts; NHEK-Ad, adult keratinocytes; CCL-241, small intestinal cells; NCM 460, colonic mucosal epithelial cells) and human tumor cell lines (MDA-MB 231 and Hs 578T, breast cancer; SK-N-FI, neuroblastoma; HeLa, cervix cancer; MIA PaCa-2, pancreatic cancer; HT-29 and HCT-116, colon cancer; DU 145, prostatic cancer cell line). Telomerase activity of these cell lines was measured by a non-PCR-based conventional assay. The effects of TMPgammaP2, TMPyP4, and AZT were also evaluated against normal human bone marrow specimens, using a granulocyte-macrophage colony-forming assay (CFU-GM). AZT showed very low cytotoxic effects against normal and tumor cell lines, with the IC50 values above 200 microM. The IC50 values for TMPyP2 and TMPyP4 in normal human cell lines were in the range of 2.9-48.3 microM and 1.7-15.5 microM, respectively, whereas in tumor cell lines the IC50 values were 11.4-53 microM and 9.0-28.2 microM, respectively. Within the tissue types, keratinocytes were more sensitive to TMPyP4 than fibroblasts, and small intestinal cells were more sensitive than colonic mucosal epithelial cells. The IC50 for TMPyP2 and TMPyP4 in the normal marrow colony-forming assays were 19.3 +/- 5.1 microM and 47.9 +/-1.0 microM, respectively. In conclusion, the in vitro cytotoxicity of the telomere interactive agent TMPyP4 is comparable in human tumor and normal cell lines, which indicates that TMPyP4 could have effects on normal tissues.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741725

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  18 in total

1.  In-silico modeling studies of G-quadruplex with soy isoflavones having anticancerous activity.

Authors:  Jyoti Singh Tomar
Journal:  J Mol Model       Date:  2015-07-12       Impact factor: 1.810

Review 2.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

3.  The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations.

Authors:  Thomas Aschacher; Sandra Sampl; Lisa Käser; David Bernhard; Andreas Spittler; Klaus Holzmann; Michael Bergmann
Journal:  Neoplasia       Date:  2012-01       Impact factor: 5.715

4.  Alteration of culture regime modifies antioxidant defenses independent of intracellular reactive oxygen levels and resistance to severe oxidative stress within confluent Caco-2 "intestinal cells".

Authors:  C S Bestwick; L Milne
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

Review 5.  Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Authors:  Jixuan Gao; Hilda A Pickett
Journal:  Nat Rev Cancer       Date:  2022-07-05       Impact factor: 69.800

6.  Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion.

Authors:  Metodi V Stankov; Reinhold E Schmidt; Georg M N Behrens
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

7.  A spherical nucleic acid platform based on self-assembled DNA biopolymer for high-performance cancer therapy.

Authors:  Jing Zheng; Guizhi Zhu; Yinhui Li; Chunmei Li; Mingxu You; Tao Chen; Erqun Song; Ronghua Yang; Weihong Tan
Journal:  ACS Nano       Date:  2013-07-23       Impact factor: 15.881

Review 8.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

9.  Cell-specific aptamers as emerging therapeutics.

Authors:  Cindy Meyer; Ulrich Hahn; Andrea Rentmeister
Journal:  J Nucleic Acids       Date:  2011-08-28

10.  Phenyl 1,2,3-triazole-thymidine ligands stabilize G-quadruplex DNA, inhibit DNA synthesis and potentially reduce tumor cell proliferation over 3'-azido deoxythymidine.

Authors:  Jerald Mahesh Kumar; Mohammed M Idris; Gunda Srinivas; Pallerla Vinay Kumar; Vuppalapaty Meghah; Mitta Kavitha; Chada Raji Reddy; Prathama S Mainkar; Biswajit Pal; Srivari Chandrasekar; Narayana Nagesh
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.